Peripheral Neuritis Overview
Peripheral neuropathy, a result of damage to the nerves located outside of the brain and spinal cord (peripheral nerves), often causes weakness, numbness, and pain, usually in the hands and feet. It can also affect other areas and body functions including digestion, urination, and circulation. Peripheral neuropathy caused by either type 1 diabetes or type 2 diabetes is called diabetic polyneuropathy. It’s probably caused by high levels of sugar in your blood damaging the tiny blood vessels that supply your nerves. Peripheral neuropathy becomes more likely the longer you have had diabetes.
Peripheral Neuritis Epidemiology Insights
Peripheral Neuritis is mainly caused by surgery and trauma and is common in clinical practice, with 13 to 23 per 1,00,000 people typically suffering from Peripheral Neuritis.
About 2.4 percent of the population is affected by Peripheral Neuritis.
The prevalence increases to 8 percent in older populations. Peripheral neuropathy can be a manifestation of a wide range of pathologies that require further evaluation and/or treatment.
Click here to learn more about the Peripheral Neuritis Market Landscape
The Report Covers the Peripheral Neuritis Epidemiology Segmented by:
Peripheral Neuritis prevalent cases
Peripheral Neuritis diagnosed cases
Peripheral Neuritis treatment cases
Peripheral Neuritis incident cases
Peripheral Neuritis Market Outlook
The Peripheral Neuritis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Peripheral Neuritis market trends by analyzing the impact of current Peripheral Neuritis therapies on the market, unmet needs, drivers, barriers, and demand for better technology. This segment gives a thorough detail of the Peripheral Neuritis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Peripheral Neuritis market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Peripheral Neuritis market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Peripheral Neuritis Market:
Novartis Pharmaceuticals
Teva Pharmaceuticals
Pfizer Pharmaceuticals
Roche Pharmaceuticals
Algo Therapeutics
Jazz Pharmaceuticals
Endo Pharmaceuticals
And many others
Peripheral Neuritis Therapies Covered and Analyzed in the Report:
Atacicept
Tapentadol
OCS-05 IV
GRC 17356
Pregabalin
WST-057
ASP3662
Learn more about the Key Companies and Emerging Therapies in the Peripheral Neuritis Market
Table of Contents
Key Insights
Peripheral Neuritis Introduction
Executive Summary of Peripheral Neuritis
Disease Background and Overview
Epidemiology and patient population
Peripheral Neuritis Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Peripheral Neuritis Market Outlook
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Adya KaulEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/consulting/due-diligence-services